Chronic inflammation is recognized as the major pathophysiological mechanism of COPD progression, with molecular targets overlapping those of CF (e.g., IL-6, CXCL8, and CCL18) [74]. The gene discussed is CCL18; the disease is chronic obstructive pulmonary disease.